{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:33:13Z","timestamp":1793424793906,"version":"4.5.0"},"reference-count":13,"publisher":"Medical Association of Nippon Medical School","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2026,10,20]]},"DOI":"10.1272\/jnms.jnms.2026_93-502","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T22:07:20Z","timestamp":1763330840000},"page":"408-414","source":"Crossref","is-referenced-by-count":0,"title":["A Case of Grade 3 Gastric Neuroendocrine Tumor with Glandular Formation: Diagnosis and Differentiation from Gastric Mixed Neuroendocrine\u2013Non-Neuroendocrine Neoplasm"],"prefix":"10.1272","volume":"93","author":[{"given":"Makiko","family":"Kurata","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, Tokai University Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Tajiri","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Tokai University Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Tokai University Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Inomoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Tokai University Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Tokai University Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tokai University Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokai University Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokai University Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokai University Hachioji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Masugi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","unstructured":"1. La Rosa Sallas B, Rindi G, Solicia E, Tang LH. Classification of neuroendocrine neoplasms of the digestive systems. Gastric neuroendocrine neoplasms. In: WHO Classification of Tumours Editorial Board, editor. Digestive system tumors: WHO classification of tumours. 5th ed. Geneva: World Health Organization; 2019. p. 104\u20139."},{"key":"2","unstructured":"2. Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Geneva: World Health Organization; 2010."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Minalyan A, Benhammou JN, Artashesyan A, Lewis MS, Pisegna JR. Autoimmune atrophic gastritis: current perspectives. Clin Exp Gastroenterol. 2017 Feb;10:19\u201327.","DOI":"10.2147\/CEG.S109123"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Konukiewitz B, Jesinghaus M, Kasajima A, Kloppel G. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls. Virchows Arch. 2022 Feb;480 (2):247\u201357.","DOI":"10.1007\/s00428-021-03211-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kasajima A, Konukiewitz B, Schlitter AM, Weichert W, Kloppel G. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features. Virchows Arch. 2022 Feb;480 (2):359\u201368.","DOI":"10.1007\/s00428-021-03202-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Volante M, Brizzi MP, Faggiano A, et al. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol. 2007 Nov;20 (11):1172\u201382.","DOI":"10.1038\/modpathol.3800954"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hijioka S, Hosoda W, Matsuo K, et al. Rb loss and KRAS mutation are predictors of the response to platinum-based chemotherapy in pancreatic neuroendocrine neoplasm with Grade 3: a Japanese multicenter pancreatic NEN-G3 study. Clin Cancer Res. 2017 Aug 15;23 (16):4625\u201332.","DOI":"10.1158\/1078-0432.CCR-16-3135"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Popa O, Taban SM, Pantea S, et al. The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5. Exp Ther Med. 2021 Oct;22 (4):1179.","DOI":"10.3892\/etm.2021.10613"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ito T, Masui T, Komoto I, et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol. 2021 Nov;56 (11):1033\u201344.","DOI":"10.1007\/s00535-021-01827-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Watanabe H, Fujishima F, Komoto I, et al. Somatostatin receptor 2 expression profiles and their correlation with efficacy of somatostatin analogues in gastrointestinal neuroendocrine tumors. Cancers (Basel). 2022 Feb 2;14 (3):775.","DOI":"10.3390\/cancers14030775"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Modlin IM, Pavel M, Kidd M, Gustafsson BI. Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumors. Aliment Pharmacol Ther. 2010;31 (2):169\u201388.","DOI":"10.1111\/j.1365-2036.2009.04174.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022 Mar;33 (1):115\u201354.","DOI":"10.1007\/s12022-022-09708-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pavel M, Oberg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Jul;31 (7):844\u201360.","DOI":"10.1016\/j.annonc.2020.03.304"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/5\/93_JNMS.2026_93-502\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:11:10Z","timestamp":1793423470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/5\/93_JNMS.2026_93-502\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2026_93-502","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"article-number":"JNMS.2026_93-502"}}